| Literature DB >> 35966907 |
Rochaya Chintavalakorn1, Nuntinee Nanthavanich Saengfai1, Kawin Sipiyaruk1.
Abstract
Low-level laser therapy (LLLT) has been widely investigated as an adjunct technique for orthodontic treatment due to photobiomodulation effect. LLLT appears to be supportive for an orthodontic practice in terms of tooth movement acceleration, pain relief, and root resorption management. The decrease in these adverse effects will enhance the compliance in orthodontic patients, which could positively impact treatment outcomes. However, there seemed to be inconsistency in the impact of LLLT as well as its laser and treatment parameters. This scoping review aimed to evaluate the impact of different irradiation parameters on tooth movement acceleration, pain relief, and root resorption as well as to construct a protocol of LLLT in orthodontic practice. The search was conducted across PubMed, Scopus, Web of Science, Embase, Google Scholar, and the reference lists of identified articles. The last search was conducted on October 10, 2021 to identify experiments in humans regarding the application of LLLT as noninvasive treatment in orthodontic practice published between 2010 and 2021. However, they were excluded if they were not clinical research, if they did not report the source of laser, or if they were not relevant to tooth movement, pain perception, and root resorption, or if they were not available in English or in full-text. Following the systematic search and selection process, 60 articles were included in this review. A majority of included articles were published in the past few years. The findings of this review supported the application of LLLT in orthodontic practice with purposes of tooth movement acceleration and pain reduction. The positive impact of LLLT on root resorption had not been clearly evident yet. As this review demonstrated heterogeneity of both laser and treatment parameters, further research should be required to ensure the effectiveness of its specific parameters in orthodontic practice. Copyright:Entities:
Keywords: LLLT; low-level laser therapy; orthodontic practice; pain; photobiomodulation; root resorption; scoping review; tooth movement
Year: 2022 PMID: 35966907 PMCID: PMC9369786 DOI: 10.4103/jispcd.JISPCD_328_21
Source DB: PubMed Journal: J Int Soc Prev Community Dent ISSN: 2231-0762
Application of LLLT for “accelerating tooth movement” in orthodontic practice
| Author(s) (year) | Type of study | Research samples | Comparison groups | Assessment | Source | Wavelength | Average radiant power | Energy density | Exposure duration | Frequency of LLLT use | Points of irradiation | Risk of bias assessment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||||
| Da Silva Sousa | Parallel-group RCT | 10 | 1. LLLT | Measurement on digital casts | GaAlAs | 780 nm | 20 mW | 5 J/cm2 | 100 | Days 0, 3, and 7 (3 days each month) | 10 (Buccal: 5; Lingual: 5) | Unclear |
| Doshi-Mehta | Split-mouth RCT | 20 | 1. LLLT | Measurement on dental casts | GaAlAs | 808 nm | 0.25 mW | Not reported | 10 | Days 0, 3, 7, and 14 in the first month, and then every 15 days | Day 1: 2 (Buccal: 1; Lingual: 1) | Low risk |
| Genc | Split-mouth RCT | 20 | 1. LLLT | Measurement in oral cavity and GCF (Nitric oxide) | GaAlAs | 808 nm | 20 mW | Not reported | 100 | Days 0, 3, 7, 14, 21, and 28 | 10 (Buccal: 5; Lingual: 5) | Unclear |
| Hasan | Parallel-group RCT | 26 | 1. LLLT | Measurement on dental casts | GaAlAs | 830 nm | 150 mW | 2.25 J/cm2 | 60 | Days 0, 3, 7, and 14 in the first month, and then every 15 days | 4 (Buccal: 2; Lingual: 2) | High risk |
| Kochar | Split-mouth RCT | 20 | 1. LLLT | Measurement on dental casts | GaAlAs | 810 nm | 100 mW | 5 J/cm2 | 100 | Days 0, 3, and 7 (3 days every 21 days) | 10 (Buccal: 5; Lingual: 5) | Low risk |
| Qamruddin | Split-mouth RCT | 20 | 1. LLLT | Measurement on 3D dental models | GaAlAs | 940 nm | 100 mW | 7.5 J/cm2 | 30 | Immediately after the force application | 10 (Buccal: 5; Lingual: 5) | High risk |
| Üretürk | Split-mouth RCT | 15 | 1. LLLT | Measurement on dental casts and GCF (IL-1β and TGF- β1) | GaAlAs | 820 nm | 20 mW | 5 J/cm2 | 100 | Days 0, 3, 7, 14, 21, 33, 37, 60, 63, and 67 | 10 (Buccal: 5; Lingual: 5) | Unclear |
| Abdelhameed and Refai, 2018[ | Split-mouth RCT | 30 | 1. LLLT | Measurement in oral cavity | GaAlAs | 810 nm | Not reported | Not reported | Not reported | Days 0, 3, 7, and 14 in the first month, and then every 15 days | Along both buccal and lingual surfaces of the root | Unclear |
| Arumughan | Split-mouth RCT | 12 | 1. LLLT | Measurement on dental casts | GaAlAs | 810 nm | 100 mW | Not reported | 100 | Days 0, 21, 42, and 63 | 10 (Buccal: 5; Lingual: 5) | Unclear |
| Guram | Split-mouth RCT | 20 | 1. LLLT | Measurement on dental casts | GaAlAs | 810 nm | 200 mW | 5 J/cm2 | 30 | Immediately after the force application | 6 (Buccal: 3; Lingual: 3) | Low risk |
| Jose | Split-mouth RCT | 12 | 1. LLLT | GCF (IL-1β and PGE2) | GaAlAs | 810 nm | 100 mW | Not reported | 100 | Immediately after the force application | 10 (Buccal: 5; Lingual: 5) | Unclear |
| Dakshina | Parallel-group RCT | 24 | 1. LLLT | Measurement on dental casts | GaAlAs | 980 nm | 2000 mW | 15 J/cm2 | 30 | Every 4 weeks | 2 (Buccal: 1; Lingual: 1) | Unclear |
| Chandran | Experimental design | 32 | 1. LLLT + Conventional bracket | Measurement on dental casts | GaAlAs | 808 nm | Not reported | 8 J/cm2 | 60 | Days 0, 3, 7, and 14 in the first month, and then every 15 days | 4 (Buccal: 2; Lingual: 2) | High risk |
| Jivrajani and Bhad, 2020[ | Split-mouth RCT | 10 | 1. LLLT | Measurement on dental casts and GCF (MMP-9) | GaAlAs | 980 nm | 30 mW | Not reported | 30 | Days 0, 3, 7, and 14 in the first month, and then every 15 days | 10 (Buccal: 5; Lingual: 5) | Low risk |
| Kamran, 2020[ | Split-mouth RCT | 44 | 1. LLLT | GCF (OPG, OPN, and RANKL) | Laser Duo, MMOptics | 808 nm | 100 mW | 25 J/cm2 | 100 | Immediately, 3 days, 1 week, and 2 weeks after the force application, and then every month | 10 (Buccal: 5; Lingual: 5) | Unclear |
| Lalnunpuii | Parallel-group RCT | 65 | 1. LLLT + Conventional bracket | Measurement on dental casts | GaAlAs | 658 nm | 8 mW | 2.29 J/ cm2 | 100 | Days 0, 3, 7, and 14 in the first month, and then every 15 days | 10 (Buccal: 5; Lingual: 5) | High risk |
| Storniolo-Souza | Split-mouth RCT | 11 | 1. LLLT | Measurement on 3D dental models | ArGaA | 780 nm | 40 mW and 70 mW (maxillary palatal) | 10 J/ cm2 and 35 J/ cm2 (maxillary palatal) | 150 | Every 4 weeks | 10 (Buccal: 5; Lingual: 5) | Unclear |
| Farhadian | Parallel-group RCT | 60 | 1. LLLT | Measurement on 3D dental models | GaAlAs | 810 nm | 100 mW | 4 J/cm2 | 18 | Days 0, 3, 30, and 60 | 6 (Buccal: 3; Lingual: 3) | Low risk |
| Qamruddin | Split-mouth RCT | 20 | 1. LLLT | Measurement on dental casts | GaAlAs | 940 nm | 100 mW | 7.5 J/cm2 | 30 | Every 3 weeks | 10 (Buccal: 5; Lingual: 5) | High risk |
| Türker | Split-mouth RCT | 20 | 1. LLLT | Measurement on 3D dental models | Epic 10; Biolase | 940 nm | 400 mW | 5 J/cm2 | 80 | Days 0, 3, 7, 14, 21, and 28 | 8 (Buccal: 4; Lingual: 4) | Unclear |
| Zheng and Yang, 2021[ | Split-mouth RCT | 12 | 1. LLLT | Measurement on 3D dental models and GCF (IL-1β, RANKL, and OPG) | Doctor Smile LAMBDA SpA | 810 nm | 100 mW | 6.29 J/cm2 | 160 | Days 0, 7, 14, and 21 | 4 (Buccal: 2; Lingual: 2) | Unclear |
|
| ||||||||||||
| Heravi | Split-mouth RCT | 20 | 1. LLLT | Measurement on dental casts | GaAlAs | 810nm | 200 mW | 21.4 J/cm2 | 300 | Immediately after the force application and on Days 3, 7, 11, and 15 | 10 (Buccal: 5; Lingual: 5) | High risk |
| Dalaie | Parallel-group RCT | 12 | 1. LLLT | Measurement on dental casts | GaAlAs | 880 nm | 100 mW | 5 J/cm2 | 80 | Not reported | 8 (Buccal: 4; Lingual: 4) | Low risk |
| Farid | Split-mouth RCT | 16 | 1. LLLT + Corticotomy | Measurement on dental casts | InAlAs | 940 nm | Not reported | 5 J/cm2 | 240 | Immediately, 1 week, 2 weeks, 3 weeks after the force application, and then every 2 weeks | 2 (Buccal: 1; Lingual: 1) | Unclear |
| Mistry | Split-mouth RCT | 21 | 1. LLLT | Measurement on 3D dental models | GaAlAs | 808 nm | 200 mW | Not reported | 80 | Days 0, 28, and 56. | 8 (Buccal: 4; Lingual: 4) | Low risk |
Application of LLLT for reducing root resorption in orthodontic practice
| Author(s) | Type of study | Research samples | Comparison groups | Assessment | Source of light | Wavelength | Average radiant power | Energy density | Exposure duration | Frequency of LLLT use | Points of irradiation | Risk of bias assessment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||||
| Nayyer | Split-mouth RCT | 22 | 1. LLLT | Root surface analysis with a non-contact 3D optical profilometer | InGaAs | 980 nm | 100 mW | Not reported | 100 | Days 0, 3, 7, 11, 15, and 28 | 10 (buccal: 5; lingual: 5) | Unclear |
|
| ||||||||||||
| Da Silva Sousa | Parallel-group RCT | 10 | 1. LLLT | Measurement on radiograph | GaAlAs | 780 nm | 20 mW | 5 J/cm2 | 100 | Days 0, 3, and 7 (3 days each month) | 10 (buccal: 5; lingual: 5) | Unclear |
| Khaw | Split-mouth RCT | 20 | 1. LLLT | Micro-CT | GaAlAs | 660 nm | 75 mW | Not reported | 120 | Every week | 8 (buccal: 4; lingual: 4) | Low risk |
| Ng | Split-mouth RCT | 20 | 1. LLLT | Micro-CT | GaAlAs | 808 nm | 180 mW 360 mW | 1.6 J/ point | 72 (cont.) 36 (pulse) | Days 0, 2, 3, 7, 14, and 21 | 8 (buccal: 4; lingual: 4) | Low risk |
| Goymen | Parallel-group RCT | 30 | 1. LLLT | Micro-CT | GaAlAs | 810 nm | Not reported | 8 J/cm2 | Not reported | Days 0, 3, 7, 14, 21, and 28 | Not reported | Unclear |
Figure 1Article’s selection process of this scoping review
Application of LLLT for “relieving pain” in orthodontic practice
| Author(s) | Type of study | Research samples | Comparison groups | Assessment | Source of light | Wavelength | Average radiant power | Energy density | Exposure duration | Frequency of LLLT use | Points of irradiation | Risk of bias assessment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||||
| Bicakci | Split-mouth RCT | 19 | 1. LLLT | VAS and GCF (PGE2) | GaAlAs | 820 nm | 50 mW | 7.96 J/cm2 | 20 | Just before and 24 h after the force application | 4 (Buccal: 2; Lingual: 2) | Unclear |
| Doshi-Mehta | Split-mouth RCT | 20 | 1. LLLT | VAS | GaAlAs | 800 nm | 0.7 mW | Not reported | 30 | Days 0, 3, 7, and 14 in the first month, and then every 15 days | Day 1: 2 (Buccal: 1; Lingual: 1) | Low risk |
| Artés-Ribas | Split-mouth RCT | 20 | 1. LLLT | VAS | GaAlAs | 830 nm | 100 mW | Not reported | 120 | Immediately after the force application | 6 (Buccal: 3; Lingual: 3) | Low risk |
| Domínguez | Parallel-group RCT | 59 | 1. LLLT | VAS | GaAlAs | 830 nm | 100 mW | Not reported | 44 | At the final acrhwire visit | Along both buccal and lingual surfaces of the root | Low risk |
| Kim | Parallel-group RCT | 88 | 1. LLLT | VAS | AlGaInP | 635 nm | 6 mW | Not reported | 120 | Every 12 h for a week | 4 (Buccal: 2; Lingual: 2) | Low risk |
| Nóbrega | Parallel-group RCT | 60 | 1. LLLT | VAS | GaAlAs | 830 nm | Not reported | Not reported | 125 | Immediately after the force application | Buccal at apex1 and interradicular 3 | Low risk |
| Eslamian | Split-mouth RCT | 37 | 1. LLLT | VAS | GaAlAs | 810 nm | 100 mW | 2 J/cm2 | 200 | Immediately after and 24 h after the force application | 10 (Buccal: 5; Lingual: 5) | Low risk |
| Marini | Parallel-group RCT | 120 | 1. LLLT | VAS | GaAs | 910 nm | 160 mW | Not reported | 340 | Immediately after the force application | 2 (Buccal: 1; Lingual: 1) | Low risk |
| Sobouti | Split-mouth RCT | 27 | 1. LLLT | VAS | He-Ne | 632.8 nm | 10 mW | 6 J/cm2 | 240 | Immediately after the force application | Along both buccal and lingual surfaces of the root | Low risk |
| Almallah | Split-mouth RCT | 36 | 1. LLLT | VAS | GaAlAs | 830 nm | 100 mW | 4 J/cm2 | 28 | Immediately after and 24 h after the force application | 16 (Buccal: 8; Lingual: 8) | Low risk |
| Bayani | Split-mouth RCT | 100 | 1. LLLT 660 nm | VAS | InGaAlP | 660 nm | 200 mW | 14.3 J/cm2 | 30 | Immediately after the force application | 6 (Buccal: 3; Lingual: 3) | Low risk |
| GaAlAs | 810 nm | 200 mW | 3.6 J/cm2 | 30 | Immediately after the force application | 6 (Buccal: 3; Lingual: 3) | ||||||
| Farias | Split-mouth RCT | 28 | 1. LLLT | VAS | GaAlAs | 810 nm | 100 mW | 2 J/cm2 | 45 | Immediately after the force application | 3 (Buccal: 3) | Low risk |
| Pesevska | Experimental design | 30 | 1. LLLT | NRS | Scorpion D-405 7A® | 630-670 nm | 20 mW | Not reported | 60/Q | Immediately after and 4 days after the force application | Not reported | High risk |
| Qamruddin | Parallel-group RCT | 88 | 1. LLLT | NRS | GaAlAs | 940 nm | 200 mW | 4 J/cm2 | 60 | Immediately after the force application | 3 (Buccal: 3) | Low risk |
| Kochar | Split-mouth RCT | 20 | 1. LLLT | VAS | GaAlAs | 810 nm | 100 mW | 5 J/cm2 | 100 | Days 0, 3, and 7 (3 days every 21 days) | 10 (Buccal: 5; Lingual: 5) | Low risk |
| Qamruddin | Split-mouth RCT | 20 | 1. LLLT | NRS | GaAlAs | 940 nm | 100 mW | 7.5 J/cm2 | 30 | Immediately after the force application | 10 (Buccal: 5; Lingual: 5) | Low risk |
| Guram | Split-mouth RCT | 20 | 1. LLLT | Wong-Baker faces pain rating scale | GaAlAs | 810 nm | 200 mW | 5 J/cm2 | 30 | Immediately after the force application | 6 (Buccal: 3; Lingual: 3) | Low risk |
| Qamruddin | Split-mouth RCT | 42 | 1. LLLT | NRS | GaAlAs | 940 nm | 100 mW | 7.5 J/cm2 | 30 | Immediately after the force application | 10 (Buccal: 5; Lingual: 5) | Low risk |
| Wu | Parallel-group RCT | 40 | 1. LLLT | NRS | GaAlAs | 810 nm | 400 mW | 2 J/cm2 | 120 | Immediately after, and then 2 h, 24 h, 4 days and 7 days after the force application | 6 (Buccal: 3; Lingual: 3) | Low risk |
| Celebi | Parallel-group RCT | 60 | 1. LLLT | VAS | GaAlAs | 820 nm | 50 mW | 1.76 J/cm2 | 96 | Immediately after the force application | 6 (Buccal: 3; Lingual: 3) | Unclear |
| Giudice | Parallel-group RCT | 84 | 1. LLLT | NRS | GaAlAs | 980 nm | 1000 mW | 27 J/cm2 for molar segment 24 J/cm2 of anterior segment | 150 | Immediately after the force application | Not reported | Low risk |
| Martins | Parallel-group RCT | 62 | 1. LLLT | VAS | GaAlAs | 830 nm | 100 mW | 95 J/cm2 | 240 | Just before and immediately after, 14 h and 28 h after the force application | 8 (Buccal: 4; Lingual: 4) | Low risk |
| Almallah | Split-mouth RCT | 36 | 1. LLLT | VAS | GaAlAs | 830 nm | 100 mW | 4 J/cm2 | 224 | An hour before and an hour after the force application | 8 (Buccal: 4; Lingual: 4) | Low risk |
| Anicic | Split-mouth RCT | 22 | 1. LLLT | VAS | Laser HF, Hager-Werken GmbH & Co. | 660 nm | 90 mW | 21.6 J/cm2 | 480 | Immediately after and 24 h after the force application | 6 (Buccal: 3; Lingual: 3) | Low risk |
| El Shehawy | Parallel-group RCT | 26 | 1. LLLT | VAS | GaAlAs | 635 nm | 20 mW | 6.5 J/cm2 | 100 | Days 0, 3, 7, and 14 in the first month | 10 (Buccal: 5; Lingual: 5) | Unclear |
| Liu | Parallel-group RCT | 150 | 1. LLLT | VAS and GCF (proinflammatory factors and pain related substance) | Nd:YAG | 1064 nm | Not reported | Not reported | 120 | Immediately after the force application and then every day for the first week | 6 (Buccal: 3; Lingual: 3) | Low risk |
| Matys | Parallel-group RCT | 76 | 1. LLLT | NRS | Lasotronix | 635 nm | 400 mW | 1.59 J/cm2 | 115 | Immediately after the force application | 23 (from maxillary right first molar to the maxillary left first molar) | Unclear |
| Nicotra | Parallel-group RCT | 56 | 1. LLLT | NRS | GaAlAs | 980 nm | 1000 mW | 1 J/cm2 | 30 | Immediately after the force application | Along both buccal and lingual sides | Low risk |
| Oza | Parallel-group RCT | 120 | 1. LLLT | VAS | GaAlAs | 830 nm | 200 mW | Not reported | 60 | Immediately after the force application | 3 (Buccal: 3) | Unclear |
| Ren | Split-mouth RCT | 27 | 1. LLLT | VAS and GCF (IL-1β, PGE2, substance P) | GaAlAs | 940 nm | 800 mW | 8.6 J/cm2 | 60 | Immediately, 1 day, 1 week, 2 weeks, 3 weeks, 4 weeks, 5 weeks, 6 weeks after the force application, and then every month | Along buccal surface of the root | Low risk |
| Sfondrini | Parallel-group RCT | 26 | 1. LLLT | Wong-Baker faces pain rating scale | GaAlAs | 830 nm | 150 mW | 7.5 J/cm2 | 20 | Immediately after the force application | 4 (Buccal: 2; Lingual: 2) | Low risk |
| Qamruddin | Split-mouth RCT | 20 | 1. LLLT | NRS | GaAlAs | 940 nm | 100 mW | 7.5 J/cm2 | 30 | Every 3 weeks | 10 (Buccal: 5; Lingual: 5) | Low risk |
|
| ||||||||||||
| Abtahi | Split-mouth RCT | 29 | 1. LLLT | VAS | GaAs | 904 nm | 200 mW | Not reported | 30 | Daily for five days | 4 (Buccal: 2; Lingual: 2) | Low risk |
| Heravi | Split-mouth RCT | 20 | 1. LLLT | VAS | GaAlAs | 810nm | 200 mW | 21.4 J/cm2 | 300 | Immediately after the force application and on Days 3, 7, 11, and 15 | 10 (Buccal: 5; Lingual: 5) | Low risk |
| Dalaie | Parallel-group RCT | 12 | 1. LLLT | Wong-Baker faces pain rating scale | GaAlAs | 880 nm | 100 mW | 5 J/cm2 | 80 | Not reported | 8 (Buccal: 4; Lingual: 4) | Low risk |
| Hasan | Split-mouth RCT | 26 | 1. LLLT | VAS | GaAlAs | 830 nm | 150 mW | 2.25 J/cm2 9 J/cm2 | 30 and 120 | Immediately after the force application | 2 (Buccal: 2) | Low risk |
| Hasan | Parallel-group RCT | 26 | 1. LLLT | VAS | CMS Dental ApS | 830 nm | 150 mW | Not reported | 60 | Immediately after the force application | 4 (Buccal: 2; Lingual: 2) | Low risk |
| Storniolo-Souza | Split-mouth RCT | 11 Average age: 14.04 | 1. LLLT | VAS | ArGaA | 780 nm | 40 mW and 70 mW (at maxillary palatal) | 10 J/cm2 and 35 J/cm2 (at maxillary palatal) | 150 | Every 4 weeks | 10 (Buccal: 5; Lingual: 5) | Low risk |
| Celebi | Parallel-group RCT | 63 | 1. LLLT | VAS | GaAlAs | 820 nm | 50 mW | 1.76 J/cm2 | 96 | Immediately after the force application | 6 (Buccal: 3; Lingual: 3) | Unclear |
| Farhadian | Parallel-group RCT | 60 | 1. LLLT | VAS | GaAlAs | 810 nm | 100 mW | 4 J/cm2 | 18 | Days 0, 3, 30, and 60 | 6 (Buccal: 3; Lingual: 3) | Low risk |